WARNINGMIXING OR WITHDRAWAL CAN BE DANGEROUS
Ordinary doses in combination with other depressants can fatally stop breathing. After prolonged dependency, stopping suddenly can also cause seizures or delirium; seek medical help.
Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Duration
Subjective Effects
Pharmacology
Pharmacodynamics
Mexazolam enhances GABA-A receptor activity at the benzodiazepine site through an active metabolite. It potentiates GABA currents at receptors containing α2 or α3 subunits, supporting its anxiolytic action. Its effect on current amplitude at α1-containing receptors is minimal.
Pharmacokinetics
Mexazolam undergoes extensive hepatic metabolism, primarily through oxidation by CYP3A isoforms, including CYP3A4, producing two principal active metabolites. Elimination is biphasic, with an initial distribution half-life of approximately 1.4 hours associated with rapid tissue uptake and first-pass metabolism, followed by a terminal half-life of about 76 hours. Plasma protein binding exceeds 90%, and gradual release from peripheral tissues contributes to the prolonged terminal phase. The active metabolites have elimination half-lives of 130-200 hours and further prolong its action.
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.
Harm Potential
Addiction & Dependence
Psychological
Mexazolam can be habit-forming.2
History & Culture
Mexazolam was marketed under the trade names Melex3 and Sedoxil4 and was investigated in clinical trials for anxiety.5
Legality
References
Citations
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed: this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Mexazolam article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.